Cancer News and Research

Latest Cancer News and Research

Experts to present latest information on multiple myeloma at Patient Symposium

The Multiple Myeloma Research Foundation and the John Theurer Cancer Center at Hackensack University Medical Center, member of the Multiple Myeloma Research Consortium, will host the MMRF Clinical Insights in Multiple Myeloma Patient Symposium on Saturday, April 2 in Short Hills, NJ from 9:00am-3:30pm.

18 Mar 2011

Experts warn radiation fears are diverting attention from public health threats in Japan

Concerns about radiation leaks from Japan's nuclear plant, which was damaged in the recent earthquake and tsunami, might be "diverting attention from potentially worse threats to public health ... like the cold and disrupted supplies of water," Reuters reports.

18 Mar 2011

GHDX presents Oncotype DX breast cancer test study results at St. Gallen conference

Genomic Health, Inc. today announced results from nine studies utilizing the Oncotype DX test in early-stage breast cancer patients at the 12th Annual St. Gallen International Breast Cancer Conference in St. Gallen, Switzerland.

18 Mar 2011

New detector technologies capable of reducing radiation dose from BSGI/MBI studies by 75%

A new study by Craig Thiessen, M.D., Director of Radiology for West Houston Radiology L.L.P. and North Cypress Medical Center in Houston, presented this week at the National Consortium of Breast Centers Annual Meeting, found the improved photon sensitivity of new detector technologies such as PSPMTs and CZT should be capable of reducing the radiation dose patient receive from BSGI/MBI studies by 75%.

18 Mar 2011

Mayo Clinic, St. Andrew's Lighthouse announce opening of Gabriel House of Care

Mayo Clinic and St. Andrew's Lighthouse, Inc. will today announce the official opening of Gabriel House of Care at a dedication ceremony on the clinic's Jacksonville campus.

18 Mar 2011

Science journal publishes CYTK preclinical cardiac myosin activation research results

Cytokinetics, Incorporated announced today the publication of preclinical research in the March 18, 2011 issue of the journal Science regarding the activation of cardiac myosin by an investigational drug candidate, omecamtiv mecarbil, and the potential therapeutic role that this novel mechanism may play for patients with systolic heart failure.

18 Mar 2011

Modified mRNA raises hope for safe and effective cancer drugs

Modern gene therapies raise hopes of combating many diseases until now considered terminal. Nowadays, however, the methods are expensive and carry a risk of severe complications.

18 Mar 2011

Scientists develop California's first detailed neighborhood database on cancer

Does living in a low-income, densely populated neighborhood such as San Francisco's Tenderloin district predispose you to a higher cancer risk than if you live in an upscale and suburban neighborhood such as San Diego's Rancho Santa Fe? Or vice versa? Scientists at the Cancer Prevention Institute of California now have the data that hold the answers.

18 Mar 2011

FDA advisory panel votes in favor of NovoTTF-100A System for supra-tentorial glioblastoma multiforme tumors

Novocure announced today that the U.S. Food and Drug Administration (FDA) Neurological Devices Advisory Panel of the Medical Devices Advisory Committee voted (7 yes; 3 no; 2 abstain) that for patients with supra-tentorial glioblastoma multiforme (GBM) tumors that recur after maximal surgical and radiation treatments, there is reasonable assurance that the benefits of the NovoTTF-100A System (NovoTTF) outweigh its risks when administered as a monotherapy in place of standard medical therapy.

18 Mar 2011

Study: Stem cells may open door to new tools for colorectal cancer detection, treatment

Colorectal cancer cells trigger a set of genes similar to those found in intestinal stem cells, scientists at the Institute for Research in Biomedicine have found.

18 Mar 2011

Major clinical studies for heart disease, stroke fail to consider participant's ethnicity

Major clinical studies that evaluate prevention strategies for heart disease and stroke fail to consider a participant's ethnicity, a factor that can more than double the rate of death in some groups, according to research led by St. Michael's Dr. Joel Ray.

18 Mar 2011

Individualized dentritic cell vaccine may increase survival time in patients with glioblastoma

A dendritic cell vaccine personalized for each individual based on the patient's own tumor may increase median survival time in those with a deadly form of brain cancer called glioblastoma, an early phase study at UCLA's Jonsson Comprehensive Cancer Center has found.

18 Mar 2011

Vitamin A may play key role in sperm cell formation and development of central nervous system

In a recently-published study mapping the structure and function of the so-called "orphan" nuclear receptor TR4, Van Andel Research Institute (VARI) investigators suggest that Vitamin A may play a more direct role than was previously known in certain physiological functions including sperm cell formation and the development of the central nervous system.

18 Mar 2011

Scientists receive £5million EU grant to identify gene targets for kidney cancer treatment

An international consortium led by scientists from the Cancer Research UK London Research Institute, The Royal Marsden Hospital and the Technical University of Denmark has been granted nearly £5million by the European Union to identify gene targets for personalised treatment for kidney cancer patients.

18 Mar 2011

INEN, MD Anderson sign sister institution agreement

The University of Texas MD Anderson Cancer Center today signed a sister institution agreement with the National Cancer Institute of Peru. Also known as the Instituto Nacional de Enfermedades Neoplásicas, INEN is Peru's sole national referral center for cancer.

18 Mar 2011

Quest Diagnostics ColoVantage molecular colorectal cancer detection test receives New York State approval

Quest Diagnostics Incorporated, the world's leading cancer diagnostics company, today announced that its ColoVantage test has been approved by New York State's Department of Health for testing on samples of patients in the state. It is believed to be the first molecular colorectal cancer detection method that employs a venal blood specimen to be approved by the state.

From Quest Diagnostics 18 Mar 2011

BUSM scientists identify new biomarker and melanoma treatment target

Researchers at Boston University School of Medicine, in collaboration with Johns Hopkins University, have identified a potential new biomarker and therapeutic target for melanoma.

18 Mar 2011

FibroGen, Astellas advance FG-4592 to phase 2b development for treatment of anemia in chronic kidney disease

FibroGen, Inc., today announced that FibroGen and partner Astellas Pharma Inc. advanced FG-4592 (Astellas designation ASP1517), an investigational anemia therapy, to phase 2b development for treatment of anemia in chronic kidney disease (CKD) patients on dialysis and not on dialysis.

18 Mar 2011

St. Michael's receives $5 million McCain donation for therapeutic endoscopy program

Wallace and Margaret McCain have donated $5 million to St. Michael's Hospital for its therapeutic endoscopy program.

18 Mar 2011

AICR awards £179,532 grant to Van Andel Research Institute for prostate cancer research

Research by scientists in America, funded by an international charity based in Scotland, could lead to new drugs for prostate cancer.

17 Mar 2011

Cancer News and Research

Latest Cancer News and Research

Experts to present latest information on multiple myeloma at Patient Symposium

Experts warn radiation fears are diverting attention from public health threats in Japan

GHDX presents Oncotype DX breast cancer test study results at St. Gallen conference

New detector technologies capable of reducing radiation dose from BSGI/MBI studies by 75%

Mayo Clinic, St. Andrew's Lighthouse announce opening of Gabriel House of Care

Science journal publishes CYTK preclinical cardiac myosin activation research results

Modified mRNA raises hope for safe and effective cancer drugs

Scientists develop California's first detailed neighborhood database on cancer

FDA advisory panel votes in favor of NovoTTF-100A System for supra-tentorial glioblastoma multiforme tumors

Study: Stem cells may open door to new tools for colorectal cancer detection, treatment

Major clinical studies for heart disease, stroke fail to consider participant's ethnicity

Individualized dentritic cell vaccine may increase survival time in patients with glioblastoma

Vitamin A may play key role in sperm cell formation and development of central nervous system

Scientists receive £5million EU grant to identify gene targets for kidney cancer treatment

INEN, MD Anderson sign sister institution agreement

Quest Diagnostics ColoVantage molecular colorectal cancer detection test receives New York State approval

BUSM scientists identify new biomarker and melanoma treatment target

FibroGen, Astellas advance FG-4592 to phase 2b development for treatment of anemia in chronic kidney disease

St. Michael's receives $5 million McCain donation for therapeutic endoscopy program

AICR awards £179,532 grant to Van Andel Research Institute for prostate cancer research

Understanding the DNA Damage Response in Innate Immunity eBook

Fourier 80: bringing benchtop NMR systems to the laboratory

How industrial hygiene flow calibration supports defensible exposure data

How electrical engineering ensures accurate calibration and patient safety

Cancer News and Research

Latest Cancer News and Research

Understanding the DNA Damage Response in Innate Immunity eBook

Fourier 80: bringing benchtop NMR systems to the laboratory

How industrial hygiene flow calibration supports defensible exposure data

How electrical engineering ensures accurate calibration and patient safety

Newsletters you may be interested in